Ophthalmic Drugs Conference 2017

SMi Group are delighted to introduce Ophthalmic Drugs which is being held on the 28th - 29th November 2017 at the Copthorne Tara Hotel in London, UK. With the Ophthalmic Drugs market being worth over $37bn in 2026 (Vision Gain), Ophthalmic Drugs 2017 will enable you to explore novel approaches into treatments, new developments in medical devices, drug delivery and pre-clinical and clinical trials in order to deepen your understanding of inherited ocular diseases. Here's a snap shot of our industry leading experts presenting this November: - Naj Sharif, Executive Director in RandD, Head, Global Alliances and External Research, Santen Inc - Mitchell de Long, Vice President, Chemistry, Aerie Pharmaceuticals - Michael Lai, Global Program Medical Director, Novartis - Sergio Leal, Ophthalmologist Director, Global Clinical Leader, Bayer - Victor Chong, Global Head of Ophthalmology, Boehringer Ingelheim - Amir Shojaei, Vice President Therapeutic Area Head, Ophthalmology, Shire - Tomas Navratil, Senior Vice President, Development, Envisia Therapeutics Take a look at the full speaker line-up! www.ophthalmicdrugs.com/evvnt - Some of the key topics addressed will involve: - Novel approaches to the treatment of ocular diseases - Advancements in ophthalmic clinical trials - Combating challenges in drug release and delivery - Animal models and regulatory considerations - Commercial potential of ocular drugs and improved patient care For those looking to attend there is currently a £300 early bird saving, for a limited time only. Further information is available at: www.ophthalmicdrugs.com/evvnt SMi is Proud to Present the Launch of... Ophthalmic Drugs Date: 28th - 29th November 2017 Location: London, UK Website: www.ophthalmicdrugs.com/evvnt Sponsors: - EXPERIMENTICA - LEICA MICROSYSTEMS ---end--- Contact Information: For all media inquiries contact Pavan Solanki on Tel: +44 (0)20 7827 6048 / Email: [email protected]